# ANDDI-PRENATOME - Feasibility Study for a " Fast " Pangenomic High Throughput Sequencing Analysis in Prenatal Diagnosis

> **NCT03964441** · — · COMPLETED · sponsor: **Centre Hospitalier Universitaire Dijon** · enrollment: 149 (actual)

## Conditions studied

- Prenatal
- Genome-wide High Throughput Sequencing

## Interventions

- **BIOLOGICAL:** Invasive fetal sampling, blood sampling of mother and father
- **BIOLOGICAL:** blood sampling from the mother to recover the circulating cell free fetal DNA
- **OTHER:** Parent interviews (optional organizational study)
- **OTHER:** parent questionnaire (optional organizational study)
- **OTHER:** professional interviews (optional organizational study)
- **OTHER:** Focus group for professionals (optional organizational study)

## Key facts

- **NCT ID:** NCT03964441
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-20
- **Primary completion:** 2021-12-20
- **Final completion:** 2024-01-25
- **Target enrollment:** 149 (ACTUAL)
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03964441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03964441, "ANDDI-PRENATOME - Feasibility Study for a " Fast " Pangenomic High Throughput Sequencing Analysis in Prenatal Diagnosis". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03964441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*